Health status measurement: An increasingly important outcome evaluation in COPD patients

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 56, Issue 4, 2001, Pages 297-298

  Carone, M ^a   Donner, C F ^a   Jones, P W ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; TIOTROPIUM BROMIDE;

ARTERIAL GAS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFICACY; DRUG RELEASE; DYSPNEA; EDITORIAL; EVALUATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; LUNG FUNCTION TEST; MORTALITY; OUTCOMES RESEARCH; PATIENT EDUCATION; PREDICTION; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SURVIVAL; SYMPTOM; TREATMENT PLANNING;

EID: 14244271206     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (24)

1. How should health-related quality of life be assessed in patients with COPD?
2. Functional status instruments: Outcome measure in the evaluation of patients with chronic obstructive pulmonary disease
3. Measuring health-related quality of life
4. The MOS Short Form General Health Survey: Reliability and validity in a patient population
5. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD
6. The Sickness Impact Profile: Development and final revision of a health status measure
7. EuroQol - A new facility for the measurement of health-related quality of life
8. A self-complete measure for chronic airflow limitation - The St George's Respiratory Questionnaire
9. A measure of quality of life for clinical trials in chronic lung disease
10. Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Quality of Life in Chronic Respiratory Failure Group
11. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
12. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
13. BTS guidelines for the management of chronic obstructive pulmonary disease
14. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary
15. Quality of life changes in COPD patients treated with salmeterol
16. The impact of COPD exacerbations (EXAC) on health related quality of life (HRQL) is attenuated by tiotropium (TIO)
17. Long-term effects of outpatient rehabilitation of COPD: A randomized trial
18. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial
19. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease
20. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
21. Quality of Life Evaluation and Survival Study: A 3-year prospective multinational study on patients with chronic respiratory failure
22. Deterioration of health in chronic respiratory failure is detected better by health status ("quality of life") questionnaires than by functional parameters
23. Mortality in chronic respiratory failure is detected better by health status (QoL) than by functional parameters